# SMTK (SmartKem, Inc.) - SEC EDGAR Financial Statements

> SmartKem, Inc. reported $585K in revenue and a net loss of $26.20M for the trailing twelve months ended September 30, 2026 (down 95.1% year over year), with a 58.5% gross margin and a -1372.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/SMTK
- Markdown: https://convexityos.com/fundamentals/SMTK.md
- SEC CIK: 0001817760
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001817760&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $585K | -95.1% YoY |
| Operating Income | TTM | -$8.03M | -1372.6% margin |
| Net Income | TTM | -$26.20M | -4478.6% net margin |
| Diluted EPS | TTM | -$33.51 | Split-adjusted |
| Free Cash Flow | TTM | -$7.86M | -1343.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $4.25M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $697K | $82K | $27K | $40K | $18K | $94K |
| Cost of Revenue | $272K | $32K | $23K | $33K | $8.0K | $55K |
| **Gross Profit** | $425K | $50K | $4.0K | $7.0K | $10K | $39K |
| Research & Development | $7.02M | $5.11M | $5.56M | $5.80M | $8.20M | $4.32M |
| Selling, General & Admin | $7.37M | $6.34M | $5.19M | $5.07M | $8.07M | $1.71M |
| Total Operating Expenses | $14.21M | $11.53M | $10.83M | $10.87M | $17.60M | $6.03M |
| **Operating Income** | -$12.84M | -$10.46M | -$9.99M | -$9.69M | -$16.30M | -$4.55M |
| **EBITDA** | -$12.62M | -$10.21M | -$9.85M | -$9.50M | -$16.09M | -$4.35M |
| Interest Income | -- | -- | $12K | $5.0K | $3.0K | $3.0K |
| Interest Expense | -- | -- | -- | -- | $19K | $6.83M |
| Income Before Tax | -$10.53M | -$10.33M | -$8.50M | -$11.47M | -$17.13M | -$23.13M |
| Income Tax Expense | -$24K | $1.0K | -- | $24K | -- | -- |
| **Net Income** | -$10.51M | -$10.33M | -$8.50M | -$11.49M | -$17.13M | -$23.13M |
| Basic EPS | -$64.50 | -$158.50 | -$316.00 | -$694.00 | -$1,188.81 | -$3,146.85 |
| **Diluted EPS** | -$64.50 | -$300.00 | -$316.00 | -$694.00 | -$1,188.81 | -$3,146.85 |
| Basic Shares Outstanding | 163.1K | 65.2K | 26.9K | 16.6K | 14.4K | 7.3K |
| Diluted Shares Outstanding | 163.1K | 65.2K | 26.9K | 16.6K | 14.4K | 7.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.0K | $0 | $20K | $561K | $81K | $32K | $23K | -- |
| Cost of Revenue | $1.0K | $0 | $4.0K | $238K | $5.0K | $28K | $1.0K | -- |
| **Gross Profit** | $3.0K | $0 | $16K | $323K | $76K | $4.0K | $22K | -- |
| Research & Development | $181K | $703K | $913K | $1.04M | $2.06M | $2.43M | $1.50M | $1.17M |
| Selling, General & Admin | $1.74M | $778K | $1.66M | $1.67M | $1.33M | $2.36M | $2.01M | $1.56M |
| Total Operating Expenses | $1.93M | $1.40M | $2.62M | $2.70M | $3.45M | $4.66M | $3.41M | $2.73M |
| **Operating Income** | -$1.92M | -$1.40M | -$2.57M | -$2.14M | -$3.19M | -$4.37M | -$3.14M | -$2.40M |
| **EBITDA** | -$1.92M | -$1.37M | -$2.54M | -$2.10M | -$3.13M | -$4.32M | -$3.08M | -$2.34M |
| Income Before Tax | -$1.52M | -$3.26M | -$19.37M | -$2.06M | -$3.92M | -$2.40M | -$2.16M | -$2.69M |
| Income Tax Expense | -- | $1.0K | -- | $0 | $0 | $1.0K | -$25K | -- |
| **Net Income** | -$1.52M | -$3.26M | -$19.37M | -$2.06M | -$3.92M | -$2.40M | -$2.13M | -$2.69M |
| Basic EPS | -$1.94 | -$7.00 | -$67.00 | -- | -$22.31 | -$15.00 | -$16.00 | -- |
| **Diluted EPS** | -$1.94 | -$7.00 | -$67.00 | -- | -$22.31 | -$15.00 | -$16.00 | -- |
| Basic Shares Outstanding | 781.9K | 470.2K | 288.7K | -- | 175.7K | 161.4K | 133.0K | -- |
| Diluted Shares Outstanding | 781.9K | 470.2K | 288.7K | -- | 175.7K | 161.4K | 133.0K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $374K | $7.14M | $8.84M | $4.24M | $12.23M | $764K |
| **Cash & Short-Term Investments** | $374K | $7.14M | $8.84M | $4.24M | $12.23M | $764K |
| Accounts Receivable, Net | $3.0K | -- | $268K | $30K | -- | $18K |
| **Total Current Assets** | $1.50M | $8.51M | $10.53M | $6.44M | $14.10M | $2.02M |
| Property, Plant & Equipment, Net | $180K | $269K | $455K | $602K | $802K | $682K |
| Other Non-Current Assets | -- | $6.0K | $7.0K | $6.0K | $6.0K | $8.0K |
| **Total Non-Current Assets** | $787K | $395K | $747K | $1.08M | $962K | $926K |
| **Total Assets** | $2.29M | $8.90M | $11.27M | $7.53M | $15.06M | $2.95M |
| Accounts Payable | $4.43M | $843K | $355K | $250K | $510K | $227K |
| Deferred Revenue (Current) | $108K | $450K | $360K | -- | -- | -- |
| Other Current Liabilities | $108K | $450K | $360K | $244K | -- | -- |
| **Total Current Liabilities** | $5.91M | $2.29M | $1.77M | $1.40M | $1.51M | $1.08M |
| Long-Term Debt | -- | -- | -- | -- | -- | $20K |
| **Total Non-Current Liabilities** | $312K | $25K | $1.39M | $239K | $28K | $20K |
| **Total Liabilities** | $6.22M | $2.31M | $3.16M | $1.64M | $1.54M | $1.10M |
| **Total Debt (incl. Leases)** | $583K | $72K | $249K | $445K | $115K | $257K |
| Common Stock | $1.0K | -- | -- | $3.0K | $3.0K | $1.0K |
| Retained Earnings | -$125.1M | -$114.6M | -$95.07M | -$86.57M | -$75.07M | -$57.95M |
| Accumulated Other Comp. Income | -$3.58M | -$1.10M | -$1.58M | -$483K | -$1.36M | -$1.48M |
| **Total Stockholders' Equity** | -$3.93M | $6.59M | $8.11M | $5.88M | $13.52M | $1.85M |
| Total Equity | -$3.93M | $6.59M | $8.11M | $5.88M | $13.52M | -$21K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.25M | $3.69M | $7.57M | $374K | $881K | $1.15M | $3.88M | $7.14M |
| **Cash & Short-Term Investments** | $4.25M | $3.69M | $7.57M | $374K | $881K | $1.15M | $3.88M | $7.14M |
| Accounts Receivable, Net | -- | -- | $3.0K | $3.0K | -- | -- | -- | -- |
| **Total Current Assets** | $4.89M | $10.36M | $8.80M | $1.50M | $2.36M | $3.43M | $5.64M | $8.51M |
| Property, Plant & Equipment, Net | -- | -- | $141K | $180K | $221K | $174K | $220K | $269K |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | $6.0K |
| **Total Non-Current Assets** | $8.48M | $0 | $676K | $787K | $884K | $852K | $274K | $395K |
| **Total Assets** | $13.37M | $10.36M | $9.48M | $2.29M | $3.25M | $4.28M | $5.91M | $8.90M |
| Accounts Payable | $481K | $380K | $3.03M | $4.43M | $4.03M | $2.02M | $738K | $843K |
| Deferred Revenue (Current) | -- | -- | $106K | $108K | -- | -- | -- | $450K |
| Other Current Liabilities | -- | -- | -- | $108K | $660K | $674K | $639K | $450K |
| **Total Current Liabilities** | $556K | $675K | $3.84M | $5.91M | $5.82M | $3.99M | $2.10M | $2.29M |
| **Total Non-Current Liabilities** | $0 | $0 | $230K | $312K | $376K | $421K | $21K | $25K |
| **Total Liabilities** | $556K | $675K | $4.07M | $6.22M | $6.20M | $4.41M | $2.12M | $2.31M |
| **Total Debt (incl. Leases)** | -- | -- | $507K | $583K | $650K | $664K | $45K | $72K |
| Common Stock | -- | $3.0K | $2.0K | $1.0K | $1.0K | -- | -- | -- |
| Retained Earnings | -$149.3M | -$147.8M | -$144.5M | -$125.1M | -$123.1M | -$119.2M | -$116.8M | -$114.6M |
| Accumulated Other Comp. Income | -- | -- | -$2.67M | -$3.58M | -$3.37M | -$4.17M | -$2.11M | -$1.10M |
| **Total Stockholders' Equity** | $12.81M | $9.68M | $5.41M | -$3.93M | -$2.95M | -$127K | $3.79M | $6.59M |
| Total Equity | $12.81M | $9.68M | $5.41M | -$3.93M | -$2.95M | -$127K | $3.79M | $6.59M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$10.51M | -$10.33M | -$8.50M | -$11.49M | -$17.13M | -$23.13M |
| Depreciation & Amortization | $212K | $258K | $145K | $198K | $209K | $197K |
| Stock-Based Compensation | $1.04M | $850K | $717K | $488K | $6.20M | -- |
| Change in Receivables | -$3.0K | $269K | -$231K | -$32K | $19K | -$17K |
| **Operating Cash Flow** | -$7.74M | -$8.10M | -$8.04M | -$9.05M | -$9.73M | -$4.08M |
| Capital Expenditure | -$123K | -$75K | -$18K | -$79K | -$341K | -$118K |
| **Free Cash Flow** | -$7.86M | -$8.17M | -$8.05M | -$9.13M | -$10.07M | -$4.20M |
| **Investing Cash Flow** | -$123K | -$75K | -$18K | -$79K | -$341K | -$118K |
| Common Stock Issued | -- | -- | $12.70M | $2.00M | -- | $4.59M |
| **Financing Cash Flow** | $1.00M | $6.53M | $12.69M | $1.83M | $22.20M | $4.59M |
| **Net Change in Cash** | -$6.77M | -$1.70M | $4.60M | -$7.99M | $11.46M | $392K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.52M | -$3.26M | -$19.37M | -$2.06M | -$3.92M | -$2.40M | -$2.13M | -$2.69M |
| Depreciation & Amortization | $0 | $29K | $36K | $41K | $58K | $57K | $56K | $64K |
| Stock-Based Compensation | $173K | $212K | $255K | $271K | $259K | $260K | $250K | $258K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Operating Cash Flow** | -$2.45M | -$1.82M | -$1.57M | -$1.42M | -$200K | -$2.78M | -$3.34M | -$1.09M |
| **Financing Cash Flow** | $4.47M | $4.55M | $8.60M | -- | -- | -- | -- | -- |
| **Net Change in Cash** | $562K | -$3.88M | $7.19M | -$507K | -$271K | -$2.73M | -$3.26M | $5.36M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 61.0% | 61.0% | 14.8% | 17.5% | 55.6% | 41.5% |
| **Operating Margin** | -1841.5% | -12761.0% | -37003.7% | -24235.0% | -90566.7% | -4840.4% |
| **Net Profit Margin** | -1507.7% | -12597.6% | -31477.8% | -28737.5% | -95144.4% | -24609.6% |
| Return on Equity (ROE) | -- | -156.7% | -104.8% | -195.4% | -126.7% | -1249.8% |
| Return on Assets (ROA) | -459.3% | -116.0% | -75.4% | -152.8% | -113.7% | -784.4% |
| Current Ratio | 0.25x | 3.72x | 5.95x | 4.59x | 9.34x | 1.88x |
| Quick Ratio | 0.06x | 3.12x | 5.15x | 3.04x | 8.10x | 0.73x |
| Debt to Equity | -- | 0.01x | 0.03x | 0.08x | 0.01x | 0.14x |
| **Revenue Growth (YoY)** | +750.0% | +203.7% | -32.5% | +122.2% | -80.9% | -- |
| Gross Profit Growth (YoY) | +750.0% | +1150.0% | -42.9% | -30.0% | -74.4% | -- |
| 5Y Revenue / Share Growth | -66.7% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 58.5% | 62.7% | 60.4% | 61.0% | -- | -- | -- | -- |
| **Operating Margin** | -1372.6% | -1404.4% | -1768.0% | -1841.5% | -- | -- | -- | -- |
| **Net Profit Margin** | -4478.6% | -4320.4% | -3997.7% | -1507.7% | -- | -- | -- | -- |
| Return on Equity (ROE) | -204.5% | -295.4% | -513.2% | -- | -- | -- | -284.3% | -156.7% |
| Return on Assets (ROA) | -196.0% | -276.2% | -292.8% | -459.3% | -343.2% | -235.1% | -182.2% | -116.0% |
| Current Ratio | 8.79x | 15.34x | 2.29x | 0.25x | 0.41x | 0.86x | 2.68x | 3.72x |
| Quick Ratio | 7.65x | 5.47x | 1.97x | 0.06x | 0.15x | 0.29x | 1.85x | 3.12x |
| Debt to Equity | -- | -- | 0.09x | -- | -- | -- | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | -95.1% | -100.0% | -13.0% | -- | -- | -20.0% | -- | -- |
| Gross Profit Growth (YoY) | -96.1% | -100.0% | -27.3% | -- | -- | -50.0% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
